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Introduction
The centrosome is the microtubule (MT)-organizing center 
(MTOC) of the cell, and mutations in centrosome-localized pro-
teins are associated with pathologies such as Huntington disease 
and lissencephaly (Sathasivam et al., 2001; Tanaka et al., 2004; 
Badano et al., 2005; Kuijpers and Hoogenraad, 2011). Centro-
somes consist of two barrel-shaped centrioles embedded in a 
protein matrix (pericentriolar material [PCM]; Bettencourt-Dias 
and Glover, 2007; Bornens, 2012). PCM is organized around the 
centriole and contains MT nucleation factors, such as -tubulin, 
pericentrin, and NEDD1, and MT nucleation complexes called 
-TuRCs (Kollman et al., 2011; Fu and Glover, 2012; Lawo 
et al., 2012; Mennella et al., 2012; Sonnen et al., 2012). Centro-
some MT nucleation capacity increases as cells approach mito-
sis, and recruitment of MT nucleation proteins is regulated in 
part by the cell cycle–dependent protein Plk1 (Polo-like kinase 1; 
Casenghi et al., 2003; Haren et al., 2009; Eot-Houllier et al., 
2010). Inhibition, depletion, or mislocalization of Plk1 during 
mitosis significantly perturbs bipolar spindle formation and 
leads to mitotic failure, in part through centrosome-mediated 
defects (Hanisch et al., 2006; Kiyomitsu and Cheeseman, 2012). 
However, how centrosome-mediated MT nucleation capacity is 
regulated during interphase is an open question.
A hallmark of tumor cells is the presence of excess (greater 
than two), or supernumerary, centrosomes (Boveri, 1888, 1901), 
which disrupt mitotic fidelity and increase aneuploidy (Kwon 
et al., 2008; Ganem et al., 2009; Silkworth et al., 2009). Endo-
thelial cells of tumor blood vessels also have high frequencies of 
excess centrosomes (Hida et al., 2004). Tumor endothelial cells 
(TECs) contribute to vessels that exhibit abnormal morphology 
and are functionally leaky once they enter a tumor (Carmeliet 
and Jain, 2011; Aird, 2012). Although cells spend most of their 
time in interphase, it is not known whether excess centrosomes 
affect nonmitotic cell processes. Tumor cells with supernumer-
ary centrosomes were overlaid with oocyte extracts containing 
tubulin monomers; the sections had more MT polymers per cell, 
but each tumor cell had numerous centrosomes, and neither MT 
Supernumerary centrosomes contribute to spindle defects and aneuploidy at mitosis, but the effects of excess centrosomes during interphase are poorly 
understood. In this paper, we show that interphase en-
dothelial cells with even one extra centrosome exhibit a 
cascade of defects, resulting in disrupted cell migration 
and abnormal blood vessel sprouting. Endothelial cells 
with supernumerary centrosomes had increased centro-
some scattering and reduced microtubule (MT) nucleation 
capacity that correlated with decreased Golgi integ-
rity and randomized vesicle trafficking, and ablation of 
excess centrosomes partially rescued these parameters. 
Mechanistically, tumor endothelial cells with supernumer-
ary centrosomes had less centrosome-localized -tubulin, 
and Plk1 blockade prevented MT growth, whereas over-
expression rescued centrosome -tubulin levels and cen-
trosome dynamics. These data support a model whereby 
centrosome–MT interactions during interphase are im-
portant for centrosome clustering and cell polarity and 
further suggest that disruption of interphase cell behavior 
by supernumerary centrosomes contributes to pathology 
independent of mitotic effects.
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Figure 1. Endothelial cell supernumerary centrosomes disrupt migration and centrosome dynamics. (A) Enriched endothelial cells (EC) from WT mouse 
mammary tissue and MMTV-PyVT+/ mammary tumors stained for PECAM1 (white, endothelial cells), pericentrin (centrosomes), and DRAQ7 (DNA). 
(right) Higher magnification of boxed areas on left without PECAM1 channel. Bars: (main images) 50 µm; (insets) 5 µm. (B) Established WT mammary 
endothelial cell (nontumor [NEC]) and tumor endothelial cell (TEC) stained for PECAM1 (white, endothelial cells), -tubulin (centrosomes), and DRAQ7 
(DNA). (right) Left images without PECAM1 channel. Bars: (main image) 50 µm; (insets) 10 µm. (C, left bars) Percentage of PECAM1-positive primary 
endothelial cells with greater than two centrosomes from tissues (MMTV-PyVT+/ skeletal muscle endothelial cells, n = 1 mouse; MMTV-PyVT/ mammary 
tissue endothelial cells, n = 10 mice; MMTV-PyVT+/ mammary TECs, n = 15 mice). Statistical comparisons to endothelial cells from control MMTV PyVT/ 
mammary tissue. 2 test; error bars shows means ± SEM. **, P ≤ 0.01; ***, P ≤ 0.001. (right bars) Percentage of established endothelial cells with greater 
than two centrosomes (WT mammary tissue endothelial cell, four clones and n = 1,082 cells; MMTV-PyVT mammary TEC, seven clones and n = 1,234 
cells). 2 test; error bars show means ± SEM. **, P = 0.013. (D) Diagram of the effect of centrosome number on cell migration. (E) 3-h migration tracks 
of TECs with one to two centrosomes or greater than two centrosomes; one representative experiment from three repeats. Bar, 40 µm. See also Video 1. 
(F) Mean total distance traveled of NECs and TECs with either one to two or greater than two centrosomes (NEC, n = 43 cells; TEC 1–2 centrosomes, 
n = 25 cells; TEC >2 centrosomes, n = 11 cells). Statistics: Student’s t test; error bars show means ± SEM. *, P = 0.02; **, P < 0.01. (G) Mean persistence 
(linear distance from origin to maximal point of migration) of NECs and TECs with either one to two or greater than two centrosomes (NEC, n = 43 cells; 
TEC 1–2 centrosomes, n = 25 cells; TEC >2 centrosomes, n = 11 cells). Statistics: Student’s t test; error bars show means ± SEM. *, P = 0.05; **, P < 
0.01. (H) Representative endothelial cells with centrosome movements tracked over 1 h. Each track starts with blue colors and ends with pink colors. Note 
the divergence of tracks over time in TECs with greater than two centrosomes. Bar, 12 µm. See also Video 2. (I) Diagram of the indicated measurements. 
(J) Centrosome–centrosome distances in indicated groups (NEC, n = 99; TEC 1–2, n = 143; TEC >2, n = 154 centrosome pairs). Statistics: Student’s t test; 
error bars show means ± SD. ***, P < 0.0001. (K) Change (absolute value) in centrosome–centrosome distance in 5-min time intervals (NEC, n = 99; 
TEC 1–2, n = 143; TEC >2, n = 154 centrosome pairs). Statistics: Student’s t test; means ± SD. ***, P < 0.0001. (L) Centrosome–nuclear edge distances 
259Excess centrosomes disrupt cell migration • Kushner et al.
nucleation frequency nor functional observations were reported 
(Lingle et al., 1998).
Directional cell migration depends on centrosome-derived 
MTs for Golgi polarization and subsequent vesicle trafficking 
to the leading edge (Petrie et al., 2009; Kaverina and Straube, 
2011; Luxton and Gundersen, 2011). Laser ablation studies re-
veal a centrosome requirement for initial Golgi organization, 
but once the MTOC is established, centrosome loss has negligi-
ble effects (Miller et al., 2009; Vinogradova et al., 2012). 
In contrast to centrosome loss, it is unclear whether excess cen-
trosomes impair cell migration.
Here, we show that the presence of even one extra centro-
some in endothelial cells leads to a cascade of defects during 
interphase, resulting in disrupted cell migration and perturbed 
vessel sprouting. Surprisingly, supernumerary centrosomes had 
reduced MT nucleations and increased dynamic centrosome 
movements, leading to Golgi fragmentation and randomized 
vesicle trafficking. Centrosome ablation to restore normal cen-
trosome numbers partially rescued centrosome dynamics, Golgi 
morphology, and directional migration. Cells with supernumer-
ary centrosomes had less centrosome-localized -tubulin, and 
Plk1 blockade prevented MT growth, whereas Plk1 overexpres-
sion (OE) rescued centrosome dynamics. Thus, centrosome–
MT interactions during interphase are important for centrosome 
clustering, and proper clustering is required for polarized be-
haviors such as migration. The disruption of interphase cell 
polarity and migration induced by supernumerary centrosomes 
may contribute to tissue disorganization and pathology.
Results
TECs with excess centrosomes  
have migration defects and  
centrosome scattering
Endothelial cells derived from tumor blood vessels (TECs) har-
bor supernumerary centrosomes (greater than two; Hida et al., 
2004). To investigate effects of supernumerary centrosomes, we 
first isolated primary TECs from mammary tumors of PyVT+/ 
female mice and counted centrosomes. Approximately 34% of 
TECs from the primary tumors had excess centrosomes, signifi-
cantly higher than normal endothelial cells (NECs) from mam-
mary tissue of PyVT/ littermates (Fig. 1, A and C). TECs were 
established in culture and analyzed for endothelial cell charac-
teristics and general properties (Fig. 1, B and C; and Fig. S1, 
A–F). Established TECs had 20% spontaneous centrosome 
overamplification, significantly elevated relative to established 
NECs (Fig. 1, B and C).
Although TECs had slightly reduced growth rates com-
pared with NECs (Fig. S1 D), TECs with excess centrosomes 
underwent mitosis and clustered extra centrosomes at the spin-
dle, as previously described (Kwon et al., 2008), and TECs 
did not have elevated apoptotic markers absent UV treatment 
(Fig. S1, E and F). However, the percentage of TECs with ex-
cess centrosomes decreased with passage number in culture 
(Fig. S1 L), although numerous primary isolates had an elevated 
frequency of centrosome amplification (Fig. 1, A and C). This 
finding suggests that, in the tumor environment in vivo, TECs 
with excess centrosomes are either maintained or replenished, 
while they are selected against in culture.
Because centrosomes form the MTOC that contributes to 
cell migration, we examined migration in endothelial cell pop-
ulations with overamplification. TECs had reduced migration 
in scratch wound and transwell assays compared with NECs 
(Fig. S1, G and H), and individual cell tracking revealed that 
TECs had reduced distance traveled and persistence (Fig. S1, 
I–K). These data indicate that TECs have an elevated frequency 
of supernumerary centrosomes and migration defects, so we 
hypothesized that excess centrosomes would disrupt migration 
(Fig. 1 D). We examined effects of excess centrosomes at the 
single-cell level via centriole labeling, which allowed us to bin 
TECs into normal (one to two centrosomes) or excess centro-
some (greater than two centrosomes) groups. Individual cell 
tracking of TECs with excess centrosomes showed significantly 
reduced migration distance and persistence compared with 
TECs with one to two centrosomes or NECs (one to two cen-
trosomes; Fig. 1, E–G; and Video 1). Interestingly, TECs with 
one to two centrosomes had reduced migration compared with 
NECs, suggesting that centrosome-independent modifications 
also contribute to TEC migration defects. To test effects of su-
pernumerary centrosomes on migration in primary cells, we in-
duced excess centrosomes in human umbilical vein endothelial 
cells (HUVECs) using either Cdc14B knockdown (KD) or Plk4 
OE (Fig. S1 M). As reported in other cells (Habedanck et al., 
2005; Wu et al., 2008), both manipulations promoted signifi-
cant centrosome overamplification, in the absence of extensive 
cytokinesis failure (Fig. S1 N). Overall growth was not affected, 
and centrosome-overamplified HUVECs clustered excess cen-
trosomes at mitosis (Fig. S1 O and not depicted). Cells infected 
with either construct had reduced migration in scratch wound 
and transwell assays and increased permeability (Fig. S1, P, Q, 
and U). Next, we assigned HUVECs into normal (one to two 
centrosomes) and overamplified (greater than two centrosomes) 
groups by labeling the centrioles. Similar to TECs, HUVECs 
containing excess centrosomes had reduced distance traveled 
and persistence in individual cell-tracking experiments (Fig. S1, 
R–T). These results indicate that excess centrosomes are associ-
ated with perturbed migration in endothelial cells.
After centriole duplication during late G1/S, centrosomes 
function as a single MTOC by associating in pairs with coordi-
nated movements (Holland et al., 2010; Sluder and Khodjakov, 
2010). Interphase centrosomes also connect to the nuclear enve-
lope via attachments between MTs and nuclear membrane proteins 
between the indicated groups (NEC, n = 130 cells; TEC 1–2, n = 142 cells; TEC >2, n = 154 measurements). Statistics: Student’s t test; means ± SD. 
***, P < 0.0001. (M) Change (absolute value) in centrosome–nuclear edge distance in 5-min time intervals (NEC, n = 130; TEC 1–2, n = 142; TEC >2, 
n = 154 measurements). Statistics: Student’s t test; error bars show means ± SD. *, P < 0.05; ***, P < 0.0001.
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diminished relatively quickly, and centrosomes came together 
(Fig. 2 A, Fig. S2 A, and Video 3). We also measured centrosome–
centrosome distance, as opposed to changes in distance, over 
time (Fig. S2 B, diagram) and found a close association be-
tween variability in dynamic centrosome movements and 
centrosome number (Fig. 2, B and C). Cells with supernumerary 
centrosomes before ablation or after a control, noncentrosomal, 
ablation had greater variability and larger changes in centrosome–
centrosome distance over time. Remarkably, normalization 
of centrosome number by ablation significantly reduced cen-
trosome–centrosome distance and overall variability, indicating 
stabilized centrosome associations (Fig. 2 C). Likewise, absolute 
centrosome–nuclear edge distance was reduced after ablation of 
excess centrosomes (Fig. S2, C and D). We next analyzed mi-
gration tracks of individual cells with excess centrosomes be-
fore and after ablation. Although distance traveled was not sig-
nificantly rescued by ablation, migratory persistence was fully 
rescued in TECs with excess centrosomes after centrosome 
ablation (Fig. 2, D and E; Fig. S2 E; and Video 4). Collectively, 
these results indicate that supernumerary centrosomes pro-
mote centrosome scattering and altered directional migration in 
interphase cells.
(Tapley and Starr, 2013). We noticed that, in TECs with excess 
centrosomes, centrosomes were more separated from each other 
and the nucleus than in cells with one to two centrosomes (Fig. 1 H 
and Video 2). During random cell migration, TECs with supernu-
merary centrosomes exhibited dynamic centrosome movements 
and abnormal centrosome positioning, as indicated by significant 
changes in centrosome–centrosome distance and centrosome–
nuclear edge distance over time (Fig. 1, I–M). These results 
indicate that supernumerary centrosomes are associated with in-
creased dynamic centrosome movements during interphase, and 
that these movements may prevent normal directional migration.
Ablation of excess centrosomes partially 
rescues centrosome scattering and 
endothelial cell migration
To determine whether perturbed cell migration and centrosome 
scattering resulted from supernumerary centrosomes, we re-
moved extra centrosomes in TECs via laser ablation (Magidson 
et al., 2007). As expected, endothelial cells with excess centro-
somes had increased centrosome movements and scattering dis-
tances before ablation. It was striking that, after ablation of the 
excess centrosome, dynamic changes in centrosome separation 
Figure 2. Ablation of supernumerary centrosomes rescues abnormal centrosome dynamics and endothelial cell migration. (A) Representative images of 
centrin::GFP-expressing TECs before and after ablation of an extra centrosome. Yellow arrow, ablated centrosome; red arrows, remaining centrosomes. 
Bar, 10 µm. See also Video 3. (B, left) Diagram showing centrosome distances between centrosomes before ablation (purple and red lines) and centrosome 
distance of the remaining centrosomal pair after ablation (green line). (right) Actual change in centrosome–centrosome distance over time for a single repre-
sentative TEC before and after centrosome ablation. (C) Individual centrosome–centrosome distances in the indicated groups (n ≥ 6 cells per condition and 
three independent experiments). Each dot represents individual centrosome–centrosome distances in the indicated cells. Statistics: Student’s t test; means ± 
SD. ***, P < 0.0001. (D) Migration tracks of TEC before and after centrosome ablation, combined from three experiments. Each color represents a single 
cell before and after ablation. Bar, 40 µm. See also Video 4. (E) Mean directional persistence of TECs in the indicated groups, labeled as in D (n ≥ 6 cells 
per condition). Statistics: one-tailed Student’s t test; error bars show means ± SEM; *, P < 0.05.
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and washout, we tested Golgi reformation in this assay and found 
it significantly impaired in cells with supernumerary centro-
somes (Fig. S3, G–I). These data indicate that supernumerary 
centrosomes perturb interphase Golgi structure and its ability to 
reform after disruption.
To better define how centrosome movements affect the 
Golgi, we tracked centrosomes (Fig. 3 F) and Golgi in migrat-
ing TECs using time-lapse imaging. Fluctuations in centrosome 
distance in cells with one to two centrosomes did not signifi-
cantly affect the Golgi, but TECs with excess centrosomes had 
elevated centrosome scattering that correlated with increased 
Golgi area (Fig. 3, A–F). Similar to the fixed image analysis, 
centrosome perimeter (a measure of centrosome scatter; Fig. S3 J, 
diagram) and Golgi area were both significantly increased in 
cells with supernumerary centrosomes (Fig. 3, G and H; and 
Videos 5 and 6). Additionally, there was moderate correlation 
Supernumerary centrosomes disrupt  
Golgi integrity
We hypothesized that excess centrosomes perturb cell migra-
tion by disrupting focal adhesion (FA) dynamics and/or Golgi 
integrity. TECs with greater than two centrosomes had reduced 
density of FA (Fig. S3, A and B). However, parameters pre-
dicted to be altered upstream of migration defects, such as FA 
size, length, or orientation, did not differ between TECs with 
one to two or greater than two centrosomes (Fig. S3 C). Centro-
somes also regulate Golgi organization; thus, we next asked 
whether supernumerary centrosomes affected Golgi morphol-
ogy. TECs stained for Golgi (GM130, a cis-Golgi protein) and 
centrosomes (-tubulin) had Golgi stacks that were more spread 
and fragmented in cells with excess centrosomes than cells with 
one to two centrosomes (Fig. S3, D and E). Because the Golgi uses 
centrosome-derived MTs to reform after nocodazole treatment 
Figure 3. Excess centrosomes disrupt Golgi integrity. (A–C) Time-lapse fluorescence micrographs of centrosomes (centrin::tdTomato; top) and Golgi 
(GalT::EGFP; bottom) in freely migrating NECs or TECs with one to two or greater than two centrosomes. Red arrows, individual centrosomes. Bars, 10 µm. 
(D–F) Plots of centrosome perimeter and Golgi area over time from images in A–C. Each graph is a single experiment from several repeats. (G and H) Box 
and whisker plot (middle bars, mean; boxes, top and bottom quartiles with error bars [SEMs]) of centrosome perimeter and Golgi area from individual 
live-cell imaging frames (NEC, n = 1,424; TEC 1–2, n = 775; TEC >2, n = 1,075 frames for both graphs). Statistics: Student’s t test; ***, P < 0.0001. 
See also Videos 5 and 6. (I) Representative images of both centrosomes (centrin::GFP, insets) and Golgi (GalT::tdTomato) in TECs with greater than two 
centrosomes before and after centrosome ablation. Red arrows, nonablated centrosomes; yellow arrow, ablated centrosome. Bars: (main images) 10 µm; 
(insets) 5 µm. (J) Representative plot from a single experiment showing centrosome perimeter and Golgi area over time from images in I, before and after 
centrosome ablation (black arrow, ablation time point). (K) Golgi area of individual TECs with greater than two centrosomes before and after centrosome 
ablation (n = 7 cells from two experiments). Statistics: one-way Student’s t test; means ± SD. *, P < 0.05.
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that they can nucleate MTs. However, TECs with excess centro-
somes had significantly decreased MT regrowth potential, pro-
ducing fewer and shorter MTs per centrosome after washout 
compared with controls (Fig. 5, F–H). Line scans indicated less 
-tubulin around supernumerary centrosomes (Fig. S4, G–I), 
and HUVECs with excess centrosomes also had decreased MT 
nucleations (Fig. S4, J–L). Collectively, these results imply that 
centrosomes in cells with excess centrosomes have reduced MT 
nucleation capacity.
Supernumerary centrosomes are deficient 
in recruitment of PCM
Because supernumerary centrosomes have decreased MT nu-
cleations, we thought that stable MTs might be reduced in this 
scenario. To avoid cell cycle–dependent PCM fluctuations, we 
arrested TECs in G1/S using a double-thymidine block and 
then assayed TECs for -tubulin (all MTs) and acetylated (Ac) 
tubulin (stable MTs) and compared radial integrated densities 
around centrosomes. We observed significantly reduced - and 
Ac-tubulin associated with supernumerary centrosomes (Fig. S5, 
A–C), with a positive association between reduced -tubulin 
and lower MT acetylation, indicating that the proportion of 
stable MTs does not change in cells with excess centrosomes 
(Fig. S5 D).
MT nucleation is regulated by recruitment of PCM com-
ponents; thus, we hypothesized that reduced MT nucleations 
result from reduced centrosomal recruitment of PCM proteins 
that promote MT nucleation, such as -tubulin and pericentrin. 
We analyzed radial integrated protein intensities at the cen-
trosomes of untreated TECs that had intact MTs. TECs with 
supernumerary centrosomes had significantly less -tubulin 
at the centrosome than did cells with one to two centrosomes, 
whereas centrosome-localized pericentrin levels were not affected 
(Fig. 6, A–C). To determine the relative amount of -tubulin 
and pericentrin bound to the centrosome in the absence of con-
tinual MT-mediated trafficking, we depolymerized MTs via 
nocodazole and found that levels of centrosomal -tubulin and 
pericentrin were significantly lower in TECs with greater than 
two centrosomes compared with cells with one to two centro-
somes (Fig. 6, B and C). We next performed laser ablation to 
normalize centrosome numbers in HUVECs with centrosome 
overamplification. HUVECs expressing Plk4 plated on a grid to 
identify centrosome-ablated cells after staining showed rescued 
centrosomal -tubulin levels within 90 min after ablation (Fig. 6, 
D and E). These results show that supernumerary centrosomes 
have reduced levels of MT-nucleating proteins resulting from 
their supernumerary status, consistent with their reduced MT 
nucleation capacity.
Reduced centrosomal PCM localization in cells with su-
pernumerary centrosomes may result from defects in recruit-
ment via MT motor proteins. Dynein stabilizes interphase MTs 
by shuttling MT nucleation proteins, and dynein alterations per-
turb MT architecture (Koonce et al., 1999). We hypothesized 
that stabilization of existing MTs around supernumerary cen-
trosomes would provide time for dynein to deposit PCM in spite 
of the lower MT abundance. To test this, we stabilized MTs 
with taxol, which fully rescued -tubulin and pericentrin levels 
between centrosome dynamics and morphological parameters, 
such as Golgi area (Fig. S3, K and L). Consistent with centro-
some scattering causing abnormal Golgi morphology, centro-
some ablation significantly rescued Golgi area (Fig. 3, I–K). 
These results suggest that supernumerary centrosomes cause 
decreased Golgi compactness and promote fragmentation.
Golgi continuity and vesicle trafficking are 
altered in cells with excess centrosomes
To determine functional consequences of Golgi changes, we ex-
amined Golgi integrity and directed vesicle trafficking. FRAP 
in the Golgi significantly lagged in TECs with excess centro-
somes, indicative of less continuity among the Golgi stacks 
(Fig. 4, A–C; and Video 7). We next monitored post-Golgi vesi-
cle trafficking by time-lapse imaging of cells labeled with 
mCherry::Rab6 (endosomes) and centrin::GFP (centrosomes). 
Among TECs with greater than two centrosomes, there were 
significantly fewer cells able to localize vesicle trafficking to 
the cell’s dominant quadrant, the presumed leading edge; in 
other words, the trajectories of post-Golgi trafficking were dis-
organized in these cells (Fig. 4, D and E; and Video 8). Simi-
larly, HUVECs with supernumerary centrosomes had more 
randomized mCherry::Rab6 trafficking compared with controls 
(Fig. 4, F and G).
Supernumerary centrosomes promote 
randomized MT growth and reduced  
MT nucleations
Golgi integrity and vesicle trafficking depend on MTs; thus, 
we hypothesized that Golgi and trafficking defects were down-
stream of MT changes. We monitored steady-state MT dynam-
ics using plus-end tip tracking (Applegate et al., 2011). TECs 
with greater than two centrosomes had more MTs emanating 
in random directions compared with controls (Fig. 5, A–C; 
and Video 9). Moreover, in HUVEC with extra centrosomes 
via Plk4 OE, MT growth polarity was randomized (Fig. S4,  
A and B). These results suggest that excess centrosomes disrupt 
post-Golgi vesicle trafficking downstream of randomized MT 
growth direction.
Centrosome pairs are clustered by MTs and dynamically 
repositioned by MT-dependent motor proteins, such as dynein 
(Robinson et al., 1999; Tanaka et al., 2004). The centrosome 
scattering and randomized MT directionality led us to hypoth-
esize that supernumerary centrosomes have MT nucleation 
defects. TECs and HUVECs with supernumerary centrosomes 
had significantly fewer MT nucleations compared with con-
trols, consistent with lower MT nucleation capacity (Fig. 5, 
D and E; and Fig. S4, C and D). However, not all MT param-
eters were altered, as cells with excess centrosomes did not ex-
hibit significant changes in MT polymerization rate or lifetime 
(Fig. S4, E and F).
To determine whether the whole-cell decrease in MT nu-
cleation was related to defects in centrosome-mediated MT nu-
cleation, we used a regrowth assay in which MTs renucleate 
after nocodazole-induced MT depolymerization and washout. 
We observed that, in cells with supernumerary centrosomes, all 
centrosomes were associated with some -tubulin, suggesting 
263Excess centrosomes disrupt cell migration • Kushner et al.
Figure 4. Excess centrosomes disrupt post-Golgi vesicle trafficking. (A) Fluorescence micrographs from time-lapse imaging depicting bleaching of Golgi 
edge (GalT::GFP) and subsequent recovery (FRAP) between TECs with one to two (top) and greater than two (bottom) centrosomes. Arrows, bleach time 
point; red circles, bleached areas; ROI, region of interest. Bars, 5 µm. See also Video 7. (B) One representative quantification of FRAP of Golgi marker 
between TECs with one to two or greater than two centrosomes from two experiments. (C) Box and whisker plots (middle bars, mean; boxes, top and 
bottom quartiles with error bars [SEMs]) of percentages of fluorescence recovery of Golgi marker 60 s after bleaching of TECs with one to two or greater 
than two centrosomes (n = 5 cells per group from two experiments). Statistics: Student’s t test; **, P < 0.01. (D) Representative single time point and time-
compressed images (1–120 s) of mCherry-Rab6 vesicle trafficking time lapse in TECs with one to two or greater than two centrosomes. Insets are higher 
magnification of corresponding centrosomes (centrin::GFP). See also Video 8. Bars: (main images) 10 µm; (insets) 10 µm. (E) Mean percentage of vesicle 
trafficking to the dominant quadrant (see Materials and methods for details; NEC, n = 25; TEC 1–2, n = 17; TEC >2, n = 20 cells; three experiments). 
Statistics: Student’s t test; *, P < 0.05; **, P < 0.01. (F) Representative images of HUVECs with one to two or greater than two centrosomes expressing 
Rab6-mCherry. (left) Single slice is one video frame, and 1–60 s are time projections. Bar, 10 µm. (G) Mean percentage of vesicle traffic to the dominant 
quadrant in HUVECs with one to two or greater than two centrosomes (HUVEC 1–2, n = 10; HUVEC >2, n = 5; two experiments). Statistics: Student’s 
t test; means ± SEM; *, P < 0.05.
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Figure 5. Excess centrosomes randomize MT polarity and reduce nucleation capacity. (A) Representative cells expressing centrin::GFP (centrosomes) and 
EB3::mCherry (growing MT plus ends). (top) Single image, with red circles indicating individual MT tips. (bottom) 30-s stack to show MT paths (blue lines). 
See also Video 9. (B) Imposition of MT growth directions onto Rose plots to visualize the percentage of growing MTs by angle in the indicated groups. 
(C) Comparison of MT angle areas from Rose plots in B. (NEC, n = 12 cells; TEC 1–2 centrosomes, n = 11 cells; TEC >2 centrosomes, n = 6 cells). Error 
bars are SEMs. (D and E) Comparison of number of MT nucleations (D) and nucleation density (E) among groups (NEC, n = 12 cells, TEC 1–2 centro-
somes, n = 11 cells; TEC >2 centrosomes, n = 6 cells). (F) MT regrowth after nocodazole washout. Indicated cells stained for MTs (-tubulin), centrosomes 
(-tubulin), and DNA (DRAQ7). (bottom) Higher magnifications of the insets. (G and H) Mean number of MTs/centrosome (G) and MT length/centrosome 
(H) in the indicated groups. (TEC 1–2 centrosomes, n = 10 cells; TEC >2 centrosomes, n = 10 cells). Error bars are SEMs. *, P < 0.05; **, P < 0.01; 
***, P < 0.001. Bars, 10 µm.
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Figure 6. Supernumerary centrosomes have 
reduced PCM. (A) Representative TECs with 
the indicated centrosome numbers arrested 
in G1/S and stained for -tubulin, pericen-
trin, and DNA (DRAQ7). Boxes show areas 
of greater magnification. Numbered yellow 
lines, line scans of -tubulin intensity shown in 
graphs to the right. Bars, 5 µm. (B and C) Ra-
dial integrated protein intensities of -tubulin 
(B) or pericentrin (C) of TECs of the indicated 
centrosome numbers in control conditions (left) 
or after nocodazole (NOC) treatment (right). 
Scatter plot with mean (middle bars) and 95% 
confidence intervals are shown for each group 
(control: TEC 1–2, n = 52 centrosomes; TEC 
>2, n = 70 centrosomes; nocodazole treat-
ment: TEC 1–2, n = 55 centrosomes; TEC >2, 
n = 57 centrosomes). Statistics: Student’s t test; 
***, P < 0.001. (D) Diagram of setup that 
allowed centrosome or control-ablated cells 
to be relocated. (E) Radial integrated protein 
intensities of -tubulin between various groups. 
Scatter plot with mean (middle bars) and 95% 
confidence intervals are shown (one to two 
centrosomes, n = 26 centrosomes; noncentro-
some ablation, n = 43 centrosomes; greater 
than two centrosomes, n = 29 centrosomes; 
after supernumerary centrosome ablation, n = 
20 centrosomes). Statistics: Student’s t test; 
***, P < 0.0001. (F) G1/S-arrested TECs 
with one to two (left) or greater than two (right) 
centrosomes in control conditions (top) or with 
BI2536 treatment and stained for -tubulin, 
pericentrin, and DNA (DRAQ7). Boxes show 
areas of greater magnification. Numbered 
yellow lines, line scans of -tubulin intensity 
graphed on the right. Bars: (main images) 
5 µm; (insets) 2.5 µm. (G) Radial integrated 
densities of -tubulin in TECs of the indicated 
centrosome numbers in control conditions 
(left) or after Bl2536 treatment (right). Scatter 
plot with mean (middle bars) and 95% confi-
dence intervals are shown (control: TEC 1–2, 
n = 28 centrosomes; TEC >2, n = 47 centro-
somes; Bl2536 treatment: TEC 1–2, n = 63 
centrosomes; TEC >2, n = 47 centrosomes). 
Statistics: Student’s t test; ***, P < 0.001. 
(H) G1/S-arrested TECs containing greater than 
two centrosomes in control conditions (left) or 
expressing Plk1::EGFP WT (right) and stained 
for (-tubulin) and DNA (DRAQ7). Numbered 
yellow lines, line scans of -tubulin intensity 
graphed to the right. Bars, 10 µm. (I) Mean 
-tubulin radial integrated protein density 
between the indicated groups normalized to 
controls. (TEC 1–2, n = 27 centrosomes; TEC 
>2, n = 27 centrosomes). Statistics: Student’s 
t test; error bars show means ± SEM; *, P < 
0.05. (J) Mean centrosome perimeter between 
indicated groups. (TEC 1–2, n = 12 cells; TEC 
>2, n = 15 cells). Statistics: Student’s t test; 
error bars show means ± SEM; **, P < 0.01. 
(K) G1/S-arrested TECs containing greater 
than two centrosomes in control conditions 
(left) or expressing Plk1::EGFP USN (destruc-
tion box mutant, right) and stained for (-tubulin) 
and DNA (DRAQ7). Numbered yellow lines, 
line scans of -tubulin intensity graphed to the 
right. White asterisk denotes cluster of excess 
centrosomes. Bars, 10 µm. (L) Mean -tubulin radial integrated protein density between indicated groups normalized to controls. (TEC 1–2, n = 29 
centrosomes; TEC >2, n = 25 centrosomes). Statistics: Student’s t test; error bars show means ± SEM; *, P < 0.05. (M) Mean centrosome perimeter be-
tween indicated groups. (TEC 1–2, n = 8 cells; TEC >2, n = 10 cells). Student’s t test; error bars show means ± SEM; **, P < 0.01. (N, left) Time-lapse 
fluorescence micrographs of G1/S-arrested TECs with one to two or greater than two centrosomes (cent) and expressing Plk1::EGFP WT (first and third 
rows), centrin::tdTomato (second row), or Plk1::EGFP USN (fourth row). Colored arrows, centrosomes. (right) Plots of centrosome perimeter over time. 
Bar, 5 µm. AU, arbitrary unit; Ctrl, control.
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centrosome scattering and loss of migratory polarity produced 
by supernumerary centrosomes would perturb vascular sprout-
ing. Using a 3D vessel sprouting assay, we analyzed sprouting 
parameters of HUVECs with an elevated frequency of supernu-
merary centrosomes, via either Cdc14B KD or Plk4 OE. Both 
manipulations produced fewer primary sprouts compared with 
controls, and Plk4 OE also reduced branching (Fig. 7, A–C). 
To investigate the contribution of individual cell movements to 
vessel morphology, we tracked nuclei of normal and centrosome- 
overamplified cells. Similar to 2D migration results, endo-
thelial cells with excess centrosomes showed significantly re-
duced total distance traveled and persistence within growing 
sprouts (Fig. 7, D–F; and Video 10). Thus, primary endothe-
lial cells with excess centrosomes have perturbed migration as 
blood vessels sprout, suggesting that interphase effects of su-
pernumerary centrosomes extend from basic cellular processes 
to tissue organization.
Discussion
Excess centrosomes promote chromosome missegregation at 
mitosis, but whether excess centrosomes affect cell behaviors 
before mitosis has not been explored. Our data show that even 
one extra centrosome induces centrosome scattering and disrupts 
cell migration during interphase and reveal a novel requirement 
for precise centrosome numbers (one to two) before mitosis. 
A model consistent with our data (Fig. 7 G) suggests that su-
pernumerary centrosomes promote imbalances in centrosome- 
localized proteins that regulate MT nucleations, leading to cen-
trosome scattering and abnormal directional migration. Elevated 
growth factor signaling promotes endothelial cell centrosome 
overamplification (Taylor et al., 2010), suggesting that centro-
some overamplification may be more prevalent than previously 
appreciated in pathologies with aberrant growth factor signaling 
(Chen et al., 2013). Elucidation of how excess centrosomes af-
fect nonmitotic cell behaviors also sheds light on mechanisms 
that regulate normal interphase centrosome functions, and the 
importance of centrosome clustering during interphase.
Excess centrosomes and cell migration
Centrosomes are MTOCs, so how do supernumerary centrosomes 
affect MT-dependent interphase cell behaviors? Our work shows 
that endothelial cells with excess centrosomes have reduced di-
rectional migration and fewer MT nucleations per centrosome, 
indicating that even one excess centrosome significantly lowers 
the MT nucleation capacity of all centrosomes. Consistent with 
our results, reduced migration was correlated with drug-induced 
loss or overstabilization of MTs in HUVECs (Myers et al., 2011). 
The dramatic rescue of directed cell migration upon ablation of 
excess centrosomes in our work strongly suggests that MT de-
fects are downstream of supernumerary centrosomes.
Although reduced MT nucleation capacity could directly 
affect directional migration, we also found defects in MT- 
dependent Golgi organization and vesicle trafficking, indicating 
disrupted polarization. Centrosome-derived MTs are largely 
responsible for Golgi coalescence, whereas Golgi-derived MTs 
primarily provide tracks for vesicle transport (Vinogradova 
of supernumerary centrosomes (Fig. S5, E and F). We next 
asked whether dynein dysfunction caused reduced protein lev-
els on supernumerary centrosomes, and we predicted that dy-
nein inhibition would reduce control centrosome-localized 
-tubulin and/or pericentrin levels to levels seen in cells with 
excess centrosomes. However, centrosomal -tubulin and peri-
centrin in control cells exposed to the dynein inhibitor cilio-
brevin D remained significantly elevated compared with cells 
with excess centrosomes, suggesting that reduced centrosomal 
-tubulin levels do not directly result from dynein-mediated de-
fects (Fig. S5, E and F; compare Fig. 6 C and Fig. S5 F). How-
ever, consistent with a previous study (Levy and Holzbaur, 
2008), dynein inhibition caused centrosomes to drift apart, sup-
porting the hypothesis that dynein is responsible for centrosome 
clustering (Fig. S5 G).
We hypothesized that one or more centrosome-localized 
regulatory factors were reduced around supernumerary centro-
somes. Plk1 is a centrosome-associated kinase that regulates re-
cruitment of -tubulin (Eot-Houllier et al., 2010). As predicted, 
antibody staining for Plk1 in TECs showed colocalization with 
-tubulin (Fig. S5 H). In interphase-arrested TECs, pharmaco-
logical inhibition of Plk1 profoundly reduced MT growth after 
nocodazole washout (Fig. S5 I), and Plk1 inhibition also caused 
a significant reduction in centrosome-localized -tubulin 
(Fig. 6, F and G). These results suggest that Plk1 is upstream of 
-tubulin recruitment to the centrosome in interphase cells, and 
it may be a limiting factor for PCM recruitment.
We predicted that if Plk1 regulates interphase -tubulin 
recruitment, elevated levels of Plk1 would alter centrosome dy-
namics. We transiently expressed wild-type (WT) Plk1 (Plk1::
EGFP WT) or Plk1 with mutations that inactivate the ubiquitina-
tion site and thus stabilized the protein (Plk1::EGFP ubiquitin site 
null [USN]; Golsteyn et al., 1994; Lindon and Pines, 2004; Elowe 
et al., 2007; Neef et al., 2007) in G1/S-arrested TECs. Both con-
ditions increased -tubulin around centrosomes after nocodazole 
washout, suggesting elevated centrosomal MT nucleation capac-
ity (Fig. S5 J). G1/S-arrested TECs with excess centrosomes 
and overexpressing WT Plk1 had more centrosome-localized 
-tubulin and significantly reduced centrosome scattering com-
pared with cells with excess centrosomes and no Plk1 manipula-
tion (Fig. 6, H–J). Similarly, G1/S-arrested TECs expressing Plk1 
USN had higher centrosome-localized -tubulin and reduced 
scattering of supernumerary centrosomes (Fig. 6, K–M). Live 
imaging of TEC with elevated Plk1 levels also showed enhanced 
centrosome clustering compared with nontransfected controls 
(Fig. 6 N). Together, these data show that increasing interphase 
Plk1 levels in cells with supernumerary centrosomes rescues cen-
trosomal -tubulin levels and reduces centrosome scattering, sug-
gesting that the increased centrosome scattering associated with 
supernumerary centrosomes results from decreased recruitment 
of -tubulin downstream of perturbed Plk1.
3D migration and blood vessel sprouting is 
compromised in endothelial cells harboring 
supernumerary centrosomes
Sprouting angiogenesis is essentially collective cell migration 
to form a blood vessel network. Thus, we hypothesized that the 
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Figure 7. Centrosome overamplification affects 3D migration and blood vessel sprouting. (A) HUVECs on microcarrier beads in sprouting angiogenesis 
assay infected with the indicated viral constructs (green) and stained with phalloidin to delineate sprout structures. Bars, 100 µm. (B and C) Mean of 
sprouts/bead (B) and branches/bead (C) in the indicated groups in a sprouting angiogenesis assay (empty vector [EV], n = 20 beads; Cdc14B KD, 
n = 20 beads; Plk4 OE, n = 8 beads). Error bars show SDs. Statistical comparisons versus empty vector. *, P < 0.05. (D) Live-imaging micrographs 
with fluorescence (centrin::GFP) overlaid on phase (see also Video 10). Arrowheads, nucleus position of a given cell at the indicated time points; blue 
ovals, nucleus. Bar, 20 µm. (insets) Fluorescence of centrosomes at higher magnification. Bar, 2 µm. White dotted lines, sprout borders. (E and F) Scatter 
plot with mean (middle bars) and 95% confidence intervals of total distance traveled (E) and persistence (F) of individual nuclei tracked within sprouts 
(1–2 centrosomes, n = 15 cells; >2 centrosomes, n = 14 cells for both graphs). *, P < 0.05; ***, P < 0.0001. (G) Model depicting mechanism of super-
numerary centrosome effects on Golgi organization, migratory polarity, and blood vessel formation. Endothelial cells with supernumerary centrosomes 
may have reduced Plk1/centrosome, leading to reduced levels of -tubulin and fewer MT nucleations/centrosome. Reduced MT nucleations compromise 
centrosome clustering at the MTOC, which leads to disorganized Golgi that randomizes vesicle trafficking and directional migration. In blood vessels, this 
abnormal migration perturbs vessel morphogenesis and integrity.
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et al., 2012). In our work, Golgi integrity was disrupted, and 
polarized vesicle trafficking was randomized by supernumerary 
centrosomes, suggesting that residual MT nucleation capacity 
of excess centrosomes exerts directional force on the Golgi. 
Increased centrosome scattering correlated with fragmented Golgi, 
and both parameters were rescued by centrosome ablation. 
In line with our results, decreased Golgi integrity disturbs polar-
ized vesicle delivery to the leading front (Yadav et al., 2009; 
Hurtado et al., 2011). Moreover, polarized transport of regula-
tors of small GTPases that affect migration, such as Rac1, is MT 
dependent (Mikhailov and Gundersen, 1998; Waterman-Storer 
et al., 1999). Consistent with this idea, MT plus-end trajectories 
were polarized in endothelial cells with one to two centrosomes 
but randomized in cells with supernumerary centrosomes.
Dynamic scattering of excess centrosomes
Our work points to insufficient centrosome clustering in endo-
thelial cells with excess centrosomes as a defect that promotes 
abnormal cell behaviors. Centrosomes cluster and connect to 
the nucleus after duplication during S phase (Holland et al., 
2010; Sluder and Khodjakov, 2010; Tapley and Starr, 2013). 
Centrosome clustering in mitotic cells with supernumerary cen-
trosomes occurs, allowing for bipolar spindle formation and 
mitotic progression (Kwon et al., 2008; Ganem et al., 2009). 
Although it was possible that excess centrosomes also clustered 
during interphase, we found that excess interphase centrosomes 
exhibit dynamic scattering that is rescued by laser ablation 
that also rescues Golgi and migration defects, suggesting that 
centrosome scattering causes interphase defects in endothelial 
cells with excess centrosomes. Interphase clustering is primar-
ily achieved through intracentrosomal MTs and dynein pulling 
forces (Koonce et al., 1999). We show that centrosome overam-
plification results in lax centrosome clustering linked to reduced 
MT nucleation capacity, although dynein blockade did not 
change the relative levels of -tubulin on centrosomes. Interest-
ingly, during mitosis, excess centrosomes clustered, allowing for 
bipolar spindle pole formation and progression through the cell 
cycle. However, endothelial cells with extra centrosomes were 
eventually lost upon passage, suggesting some loss of fidelity.
As cells approach mitosis, centrosomes recruit factors that 
enhance MT nucleation capacity and set up the spindle (Casenghi 
et al., 2003; Haren et al., 2009; Eot-Houllier et al., 2010). Spe-
cific changes include recruitment and activation of Plk1, which 
promotes recruitment of -tubulin and pericentrin and increased 
centrosome MT nucleation capacity (Elowe et al., 2007). 
We hypothesized that parallel mechanisms regulate interphase 
centrosome MT nucleations and are disrupted in cells with su-
pernumerary centrosomes. Consistent with this hypothesis, cells 
with supernumerary centrosomes had reduced centrosome- 
localized -tubulin and pericentrin, and -tubulin levels were 
rescued by ablation of excess centrosomes. Moreover, our data 
indicate that Plk1 regulates centrosome function during interphase 
because Plk1 blockade reduced MT growth and centrosome-
localized -tubulin levels, mimicking the effects of supernu-
merary centrosomes, whereas overexpression restored -tubulin 
levels and reduced centrosome scattering. It may be that a lim-
ited pool of Plk1 is active during interphase, and this pool does 
not change with centrosome number. In this scenario, supernu-
merary centrosomes would effectively dilute the active Plk1 
available at each centrosome and promote reduced MT nucle-
ations. This model is supported by a report that supernumerary 
centrosomes nucleated supernumerary cilia, but each cilium 
had reduced signaling capacity (Mahjoub and Stearns, 2012). 
Moreover, other factors likely also affect centrosome clustering, 
because we observed differences in MT-nucleating capacity be-
tween normal and TECs independent of centrosome number.
Conclusions
The centrosome-clustering defects we observed indicate that 
interphase endothelial cell centrosomes are less buffered to per-
turbations than mitotic centrosomes, and that they require pre-
cise levels of PCM components to function properly, such that 
relatively subtle changes have significant effects on centrosome 
clustering and polarized cell behaviors. The effects of supernu-
merary centrosomes on centrosome dynamics, MT regulation, 
and directional migration have implications for tissue organiza-
tion. Populations of endothelial cells harboring excess centro-
somes do not sprout efficiently, and endothelial cells with excess 
centrosomes have reduced migration within sprouts. Given that 
30% of TECs have supernumerary centrosomes and do not 
express tumor markers, they probably originate from normal 
vessels. The tumor likely provides an environment conducive to 
centrosome overamplification, perhaps via elevated growth fac-
tor signaling (Taylor et al., 2010). Thus, abnormal directional 
migration downstream of centrosome overamplification is likely 
to be a novel mechanism whereby TECs sustain migration de-
fects that contribute to the documented abnormalities of tumor 
vessels. Indeed, it is tempting to speculate that bone fide tumor 
cells, which exhibit even more profound centrosome overampli-
fication, also alter their responses to environmental cues down-
stream of supernumerary centrosomes.
Materials and methods
Cell isolation, culture, and viral transduction
HUVECs and human lung fibroblasts were grown under standard condi-
tions. Lentivirus expressing a GFP reporter (GiPZ; GE Healthcare), shRNA 
against Cdc14B (GiPZ), or cytomegalovirus (CMV)-driven full-length human 
Plk4 (pcDNA3.1 3×myc-A; gift from E. Nigg, University of Basel, Basel, 
Switzerland) were first cloned into pCR8/GW/TOPO (Invitrogen) and then 
inserted into several lentiviral backbones using a conventional Gateway LR 
reaction (Life Technologies): pLenti CMV GFP DEST (736; 19732; Add-
gene), pLenti CMV neomycin (Neo) DEST (705-1; 17392; Addgene), and 
pLIX 402 (41394; Addgene). Human full-length Plk1 was cloned from a 
pEGFP-C1 construct (37406; Addgene) and inserted into a pEGFP-N1 
backbone (Takara Bio Inc.). USN Plk1 was generated by introducing the 
mutations R337A and L340A using fusion PCR. Centrioles were visualized 
with a centrin::EGFP (human centrin-2)-expressing lentivirus (pLentiLox 7.0 
CMV), a centrin::dsRed lentivirus (pLentiLox 7.0 CMV), or a centrin::tdTo-
mato lentivirus (pLentiLox CMV). For MT tracking, lentivirus (pLenti CMV 
Neo DEST (705-1)) expressing full-length EB3::mCherry (gift from V. Small, 
Institute of Molecular Biotechnology, Vienna, Austria) or full-length EB1::
EGFP was generated by subcloning into pCR8/GW/TOPO and then clon-
ing into lentiviral destination vector (pLenti CMV Neo DEST (705-1)). For 
Golgi visualization, a CMV-driven galactosyltransferase (GalT)::EGFP was 
used (gift from J. Lippincott-Schwartz, National Institutes of Health, 
Bethesda, MD). Vesicles were marked with full-length Rab6a::EGFP (pEGFP-
N1 CMV; gift from J. Lippincott-Schwartz). HUVECs were incubated in 
media with virus and 1 µg/ml polybrene (EMD Millipore) for 24 h and then 
in media for 24 h.
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94°C for 30 s, annealing at 52–62°C for 30 s, and extension at 72°C for 
30 s, with the final extension at 72°C for 10 min. Products were resolved 
on 1.5% agarose gels.
Western blot analysis
Western blot analysis was performed as previously described (Kappas 
et al., 2008). In brief, cells were lysed in radioimmunoprecipitation assay 
buffer containing protease inhibitor cocktail (Sigma-Aldrich). 50 µg protein 
was separated on a 10% SDS-polyacrylamide gel and transferred to a 
polyvinylidene fluoride membrane (GE Healthcare). Primary antibodies 
used were rabbit anti-Cdc14B (1:200; Invitrogen), rabbit anti-Plk4 (1:250; 
Sigma-Aldrich), rabbit anti–cleaved caspase (1:1,000; Abcam), goat anti-
actin (1:5,000; Santa Cruz Biotechnology, Inc.), and goat anti-GAPDH 
(1:5,000; Abcam). The HRP-tagged secondary antibodies included anti–
rabbit IgG (1:1,000; GE Healthcare) and anti–goat IgG (1:1,000; Santa 
Cruz Biotechnology, Inc.), which were visualized using enhanced chemilu-
minescence (GE Healthcare).
Sprouting angiogenesis assay
The sprouting assay was performed as previously described (Nakatsu et al., 
2007). In brief, HUVECs were mixed with Cytodex beads, incubated with 
agitation at 20-min intervals for 4 h, and then plated overnight. HUVEC-
coated beads were washed in PBS and resuspended in PBS with 2 mg/ml 
fibrinogen, thrombin was added to form fibrin, and human lung fibroblasts 
were seeded on top of the fibrin plug. Media were changed every 2 d, 
and cultures were fixed at day 7 with 4% PFA and stained with phalloidin 
(Invitrogen) to visualize F-actin or live imaged on days 5–6. Images were 
acquired using a confocal microscope (LSM 5 Pascal) and 10× air objec-
tive at RT. Sprout and branch analyses were performed using the BoneJ 
plugin for ImageJ software (National Institutes of Health). For live imaging, 
HUVECs were co-infected with tetracycline-inducible Plk4 and centrin::GFP 
lentivirus and then incubated with media containing 500 ng/ml doxycy-
cline from day 0 to 2 of the sprouting assay. Live imaging was performed 
on days 5–6 using a live-imaging system (FV1200; Olympus) at 37°C 
with 5% CO2 and glass-bottom 35-mm dishes. Confocal stacks were ac-
quired every 20 min with a U Plan S Apochromat 40×, 1.25 NA silicon 
objective (Olympus).
Centrosome ablation
TECs expressing centrin::GFP were plated on glass-bottom dishes (MatTek 
Corporation) coated with 2 µg/ml fibronectin or HUVEC on a gridded mi-
cropattern. Cells were live imaged in an environmental chamber on an 
FV1000 at 10-min intervals for 2–3 h before centrosome ablation. Laser 
ablation was performed as previously described (Magidson et al., 2007). 
In brief, ablations were performed using a Ti:sapphire laser (Olympus) at 
12% power at 900 nm for 10 s and a 60×, 1.42 NA Plan Apochromat 
objective. In some cells, a third centrosome was ablated, and controls con-
sisted of a similar ablation distant from the centrosomes. For each cell, a 
comprehensive z stack was acquired before and immediately after the 
laser pulse to confirm centrosome ablation. After ablation, cells were moni-
tored for 2–3 h. HUVECs on micropattern grids were fixed and stained for 
-tubulin (mouse monoclonal anti–-tubulin; GTU88 clone; 1:1,000) 90 min 
after ablation, and coordinates were used to identify cells that had experi-
enced centrosome ablation.
MT regrowth and MT dynamics
Cells plated on glass-bottom fibronectin-coated plates were incubated in 
5 µg/ml nocodazole (in DMSO; Sigma-Aldrich) for 2 h at 37°C. After 5× 
washes in cold PBS, cells were warmed to 37°C and fixed at various inter-
vals with 100% MeOH. MTs and centrosomes were visualized by immuno-
fluorescence using mouse anti–-tubulin Alexa Fluor 555 conjugate (1:250) 
and mouse anti–-tubulin (1:5,000; Sigma-Aldrich). Images were acquired 
using a confocal microscope (LSM 5 Pascal) and 63×, 1.4 NA oil objective 
at RT. Line scans were generated using a 10-µm line drawn through the 
centroid of the MT-nucleating center and the centroid of the nucleus.
For MT tip tracking, cells were imaged on an inverted spinning-disk 
confocal microscope (TE2000E; Nikon) using a 60×, 1.2 NA oil immer-
sion objective (Carl Zeiss). Images were captured using a camera (Or-
caER; Hamamatsu Photonics) and SimplePCI software (Hamamatsu 
Photonics). Excitation was provided by a 100-mW Krypton/Argon laser 
and scan head (Yokogawa Electric Corporation). Acquisitions of EB1/3 
videos used a cooled charge-couple device operated by a 16-bit mode at 
1–2-s intervals for 1 min. MT dynamics were analyzed using the plusTip-
Tracker software program (Jaqaman et al., 2008) and processed as previ-
ously described (Myers et al., 2011). In brief, plusTipTracker is a MATLAB 
Isolation of TECs
Mouse cells were isolated via magnetic bead-assisted cell sorting (MACS; 
Miltenyi Biotec) as previously described (Dudley et al., 2008), with modi-
fications. Female MMTV-PyVT (mouse mammary tumor virus–polyoma mid-
dle T antigen) transgenic mice and WT littermates were sacrificed when 
tumors were 1–1.5 cm2. Tissue was minced and incubated in 2 µg/ml 
collagenase (Worthington Biochemical Corporation) for 75 min and then 
passed through a 70-µm strainer. Cells were washed in PBS, resuspended 
in autobuffer (autoMACS), and incubated with rat anti–mouse polyclonal 
platelet endothelial cell adhesion molecule (PECAM) conjugate to phyco-
erythrin (PE) antibody (1:1,000; BD) and then with anti-PE microbeads 
(Miltenyi Biotec). Labeled cells were passed through an LS column (Milt-
enyi Biotec) on a magnetized stand and washed 3× with autobuffer (auto-
MACS) before elution into MACS buffer. Cells were pelleted, plated onto 
gelatin-coated Petri dishes in DMEM media containing 20% FBS and a 
cell growth kit (EGM-2 SingleQuot; Lonza), and maintained at 10% CO2. 
Some MACS-isolated cells were incubated with media containing polyoma-
virus middle T–expressing virus for 3 d and then selected for resistance to 
neomycin (Balconi et al., 2000). Endothelial cell colonies were identified 
by DiI-acLDL (1,1-dioctadecyl-3,3,3,3-tetramethyl-indocarbocyanine per-
chlorate) uptake (L-23380; Invitrogen) and picked for expansion. For FACS 
analysis, cells were detached with Accutase, washed, and resuspended 
in PBS/0.1% BSA containing rat anti–mouse polyclonal PECAM-PE– 
conjugated antibody (1:1,000; BD). After three washes, cells were ana-
lyzed using a flow cytometer (FACSCalibur; BD).
Centrosome counts
HUVECs were stained with rabbit polyclonal anti-pericentrin (1:1,000; 
Abcam) or mouse monoclonal anti–-tubulin (GTU88 clone; 1:1,000; 
Sigma-Aldrich) to visualize centrosomes, mouse monoclonal anti–-tubulin 
Alexa Fluor 555 conjugate (1:1,000; EMD Millipore) to visualize MTs, and 
DRAQ7 or DAPI to visualize nuclei. Individual centrosomes were scored 
as either -tubulin– or pericentrin-positive dots adjacent to the nucleus with 
distinct separation from neighboring centrosomes. PECAM-enriched mouse 
cell isolates were incubated for a maximum of 72 h, and these cells or 
established mouse endothelial cells were fixed and stained for -tubulin, 
rat monoclonal anti-CD31 (1:1,000; Invitrogen), and DNA (DRAQ7; Bio-
Status), and centrosome counts were performed. Images were acquired 
using a confocal microscope (LSM 5 Pascal; Carl Zeiss) and a 63×, 1.4 
NA oil objective at RT.
Scratch wound, transwell, and random cell migration assays
Scratch wound assays were performed by plating 104 cells/well and 
growing to confluence. A linear scratch was made down the middle of 
the well, and media were exchanged. Cells bordering the wounded area 
were imaged at 20× magnification at t = 0 and t = 5 h. The relative clo-
sure for each condition was calculated using the difference in distances 
between the opposing sides of the wound before and after incubation, with 
10 measurements/area.
Transwell assays were performed using a Transwell kit (12-well at 
8 µm; Corning) with the membrane seeded with 1 × 104 cells. After 24 h, 
cells were serum starved with Opti-MEM media (Gibco) overnight, and 
then, the upper chamber (containing cells) was transferred to a well con-
taining DMEM with 20% FBS and incubated for 5 h. Cells were fixed and 
stained using the stain set (Protocol Hema 3; Thermo Fisher Scientific), and 
the number of cells on the bottom of the transwell was counted.
Random cell migration was performed using cells that were sparsely 
plated on 35-mm glass-bottom dishes (MatTek Corporation) coated with 
2 µg/ml fibronectin. Cells were imaged at 5-min intervals for 3 h using an 
imaging system (BioStation IM; Nikon), with a 20×, 0.45 NA phase objec-
tive. Tracks were analyzed with mTrackJ software (Meijering Laboratory).
Growth curves and mitotic cell assessment
Cells were plated at a density of 103 cells per well in triplicate and then 
trypsinized and counted every 2 d. To identify mitotic cells, fixed cultures 
were incubated with rabbit anti–phosphohistone-3 Alexa Fluor 555 conju-
gate (1:1,000; Cell Signaling Technology) and DRAQ7 (1:1,000; Abcam; 
20 min at RT) was used to visualize nuclei.
RT-PCR
Total RNA was isolated with TRIZOL reagent (Invitrogen), and 1 µg RNA 
was used to synthesize cDNA using a cDNA synthesis kit (iScript; Bio-Rad 
Laboratories, Inc.). 2 µl of the threefold diluted cDNA was used as a tem-
plate for PCR using Taq PCR Core kit (QIAGEN). The sample was dena-
tured at 94°C for 3 min and then subjected to 26 cycles of denaturation at 
JCB • VOLUME 206 • NUMBER 2 • 2014 270
Statistics
Error bars represent SEMs, except where noted. 2 analysis was used for 
centrosome count comparisons, one-tailed Student’s t test was used for pre- 
versus postablation comparisons, and two-tailed Student’s t test was used 
for the remainder of the statistical analyses.
Online supplemental material
Fig. S1 characterizes TECs and HUVECs with supernumerary centrosomes. 
Fig. S2 shows the effects of centrosome ablation on centrosome dynam-
ics and migration. Fig. S3 shows how excess centrosomes affect FAs and 
Golgi. Fig. S4 shows excess centrosome-mediated changes in MT dynam-
ics in TECs and HUVECs. Fig. S5 shows effects of excess centrosomes on 
PCM. Video 1 shows TECs with excess centrosomes and blunted migration. 
Video 2 shows HUVECs with excess centrosomes and blunted migration. 
Video 3 shows that ablation of excess centrosome restores centrosome 
clustering. Video 4 shows that ablation of excess centrosome restores di-
rectional migration. Videos 5 and 6 show Golgi integrity reduced in cells 
with excess (two [Video 5] or greater than two [Video 6]) centrosomes. 
Video 7 shows extended FRAP in Golgi of cells with excess centrosomes. 
Video 8 shows randomized vesicle trafficking in cells with excess centro-
somes. Video 9 shows some changed MT tip-tracking outputs in cells with 
excess centrosomes. Video 10 shows normal migration of HUVEC with one 
to two centrosomes and reduced migration of HUVECs with greater than two 
centrosomes within blood vessel sprouts. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201311013/DC1.
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